Telo Genomics Corp. has developed and implemented a machine learning and AI tool, CellSelect-Pro, to enhance the processing of samples in their TeloView myeloma…
Browsing: Clinical Trial
NeuroSense and PhaseV are collaborating to use causal machine learning for clinical trial analysis and optimization of NeuroSense’s ALS therapy. The therapy, PrimeC, is…
NeuroSense Therapeutics and PhaseV have partnered to use causal machine learning to analyze and optimize the planned Phase 3 trial of PrimeC as a…
This article discusses the use of machine learning algorithms in predicting obesity and overweight, with a focus on improving early identification and risk assessment.…
Syneos Health and KX have announced a strategic partnership to leverage data analytics and AI to accelerate clinical trial execution. The partnership will provide…
This article explores the differences between potential target sites generated using individualized RSNM (RSNM-based targets), standard anatomical methods (structural targets), and the point of…